Related references
Note: Only part of the references are listed.Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Ashish B. Rajput et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers
Wennuan Liu et al.
GENES CHROMOSOMES & CANCER (2007)
TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications
Marc Barry et al.
UROLOGY (2007)
Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases
Rohit Mehra et al.
CANCER RESEARCH (2007)
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer:: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues
Jiangling J. Tu et al.
MODERN PATHOLOGY (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
Fluorescent in situ hybridization on tissue microarrays: challenges and solutions
Lindsay A. Brown et al.
JOURNAL OF MOLECULAR HISTOLOGY (2007)
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
J. Clark et al.
ONCOGENE (2007)
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Jacques Lapointe et al.
MODERN PATHOLOGY (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Nuno Cerveira et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Maria Johansson Soller et al.
GENES CHROMOSOMES & CANCER (2006)
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement
Maisa Yoshimoto et al.
NEOPLASIA (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1
Y Birger et al.
CANCER RESEARCH (2005)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
G Petrovics et al.
ONCOGENE (2005)
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma
N Makretsov et al.
GENES CHROMOSOMES & CANCER (2004)
Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study
JM Lubieniecka et al.
PROSTATE (2004)
ESEfinder: a web resource to identify exonic splicing enhancers
L Cartegni et al.
NUCLEIC ACIDS RESEARCH (2003)
General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the prostate cancer outcomes study
DF Penson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
